Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis

• Status: Completed
• Trial end date: 2008-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy of etanercept and sulphasalazine in the treatment of Ankylosing Spondylitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Etanercept; Sulfasalazine

Criteria

Inclusion Criteria:

• Clinical diagnosis of ankylosing spondylitis

• Active ankylosing spondylitis

Exclusion Criteria:

• Complete ankylosis of spine

• Previous treatment with etanercept